23, 25, 26-trihydroxycholecalciferol. A 25-hydroxycholecalciferol-26,23-lactone precursor

Area of Science:

• Endocrinology
• Metabolism
• Biochemistry

Background:

• Vitamin D metabolism is crucial for calcium homeostasis and bone health.
• The conversion of vitamin D metabolites involves complex enzymatic pathways, particularly in the kidney.
• Understanding these pathways is essential for managing vitamin D-related disorders.

Purpose of the Study:

• To investigate the metabolic fate of (23S)-23,25-dihydroxycholecalciferol in avian kidney homogenates.
• To identify novel vitamin D metabolites and their biochemical transformations.
• To elucidate specific enzymatic activities in chicken kidney relevant to vitamin D processing.

Main Methods:

• Incubation of (23S)-23,25-dihydroxycholecalciferol with kidney homogenates from vitamin D-treated chickens.
• Separation and analysis of metabolites using techniques such as UV-absorbance, mass spectrometry, and derivative formation.
• Characterization of identified metabolites through spectroscopic and chemical methods.

Main Results:

• At least five distinct metabolites were formed from (23S)-23,25-dihydroxycholecalciferol.
• 23,25,26-trihydroxycholecalciferol was positively identified as a major metabolite.
• 23,25,26-trihydroxycholecalciferol was shown to be further converted into 25-hydroxycholecalciferol-26,23-lactone in the same homogenates.

Conclusions:

• Chicken kidney homogenates possess enzymatic activity capable of metabolizing (23S)-23,25-dihydroxycholecalciferol.
• 23,25,26-trihydroxycholecalciferol is a significant intermediate in this metabolic pathway.
• The formation of 25-hydroxycholecalciferol-26,23-lactone suggests a specific enzymatic conversion pathway in avian vitamin D metabolism.